Sitemap

Home
About
- Amgen History Awards and Accolades How We Operate
  - Business Ethics and Compliance
    - Annual Declaration of Compliance Elements of an Effective Compliance Program Amgen’s Culture of Compliance Staff Code of Conduct Corporate Compliance Policies Reporting a Concern
    Corporate Governance
    - Board of Directors Guidelines for Director Qualifications and Evaluations Duties and Responsibilities of the Lead Independent Director Amgen Board of Directors Corporate Governance Principles Audit Committee Compensation and Management Development Committee Corporate Responsibility and Compliance Committee Equity Award Committee Executive Committee Charter Governance and Nominating Committee Board of Directors Code of Conduct Staff Code of Conduct Supplier Code of Conduct Code of Ethics for CEO and Senior Financial Officers Policy on Executive Compensation in Restatement Situations Rights Plan Policy
    Policies, Practices and Disclosures
    - Human Rights Commitment Ethical Research
      - Global Code of Ethics for Clinical Trials Clinical Trial Transparency, Data Sharing and Disclosure Practices
        
        Clinical Trial Data Sharing Request
        
        Amgen Guidelines for Publications Amgen Position Statement on Stem Cell Research Biobanking of Human Samples Adverse Event and Product Complaint Reporting Commitment to the Ethical Use of Animals in Research Amgen Statement on Compendia R&D Gifts Policy
      Responsible Marketing and Product Information
      - Direct-to-Consumer (DTC) Advertising Interactions With Healthcare Providers Post-Marketing Commitments/Post-Marketing Requirements
      Corporate Giving
      Business Conduct
      - Quality Protection of Personal Information Insider Trading Conflicts of Interest Antitrust and Unfair Competition Political Activities
      Work Environment
      - Professional Conduct Safe and Healthy Workplace Environment, Health, and Safety Equal Employment Opportunity Non-Discrimination and Harassment Free Workplace Compliance Reporting and Non-Retaliation
      International Trade
      - Economic Sanctions, Embargoes, and Boycotts Export and Import Control Laws Anti-Bribery and Anti-Corruption
      Transparency Disclosures
      - Donation and Grant Recipients
        
        Independent Medical Education and Healthcare Donations Amgen Foundation Grants European Donations to Patient Groups
        
        Donations & Grant Disclosures FAQs
        
        Political Contributions U.S. Healthcare Professionals and Entities EFPIA Disclosures
      Privacy Pledge to Patients
  Leadership
  - Senior Management
    Board of Directors
    Scientific Advisory Boards
  Mission and Values
KRAS Information Center
Science
- Clinical Trials
  - About Clinical Trials Clinical Trial Transparency, Data Sharing and Disclosure Practices
    - Clinical Trial Data Sharing Request
    Clinical Out-of-Hours Support Program Clinical Trial Diversity and Representation
    - Amgen's Commitment to Clinical Trial Diversity
    Information for Healthcare Professionals
    - Research Philosophy Investigator Resources Investigator Survey
  DNA Unlocked Manufacturing
  - Innovation Quality Reliability Stories
  Research and Development Strategy Scientific Advisory Boards Scientific Community Initiatives
  - Educational Outreach Program Postdoctoral Fellows Program
    Scientific Conferences Program Start-Up Network Program
  Undruggable
Teneobio
Products
- Counterfeit Drug Statement Global Patient Safety
  - Who We Are Our Commitment What We Do Adverse Event and Product Complaint Reporting
  Safety Data Sheets
Responsibility
- 2019 Responsibility Highlights Report
  - Access to Medicine Business Ethics Community Environment Forward Looking Statements Letter From Bob Bradway Our Response to COVID-19 Reporting and Metrics Workplace
  Corporate Responsibility Strategy & Governance
  - Amgen’s Commitment to Patients
  Environmental, Social & Governance Report 2020 Our Approach to Pricing, Access and Affordability
  - Access Approaches, Treatments, and Collaborations
    - Responsible Approach to Pricing
      - Amgen’s Approach to Responsible Pricing
      Value-based Contracts Biosimilars Access to Medicine and Patient Support Programs
      - Access to Medicine
        
        U.S. Reimbursement Support Services and Financial Assistance Programs Access to Medicines Initiatives Outside the U.S.
        
        Pricing and Patient Support Health System Strengthening Product Donations R&D, Manufacturing and Distribution
        
        Access to Investigational Medicines
    Transformative Treatments, Approaches, and Technology
    - Precision and Personalized Medicine Digital Health Solutions
    Shaping the Future of Healthcare
    - Investing in Innovation to Transform Therapies in Healthcare Health System Solutions
  Amgen Foundation
  - Amgen Foundation Grants
    - Amgen Foundation Grant Guidelines Letter of Inquiry Checklist Grant Application Checklist Amgen Foundation Grant FAQs
  Commitment to Community
  - Staff Engagement Independent Medical Education Funding
    - Independent Medical Education FAQs Budget Instructions Contact Us
    U.S. Healthcare Donations
    - Eligibility Criteria Healthcare Donations FAQs Contact Us
    Non-Healthcare Donations and Sponsorships
    Equipment Donations
  Diversity, Inclusion and Belonging
  - Amgen's Commitment to Diversity, Inclusion and Belonging
  Environment
  - Performance
    - Carbon Water Waste Fuel Efficiency Targets
    2027 Plan Sustainable by Design
    - Product Sustainability Green Buildings
    Case Studies
  Responsible Sourcing
  - Supplier Sustainability
    - California Supply Chain Transparency Act
  Reporting and Metrics
  - Summary of Data CDP Stakeholder Engagement Archived Reports
  Workplace
  - Safety Wellness
Newsroom
- Image Library Company Statements
  Global Contact Info
Partners
- Academic Collaborations
  - New Requests
    - Special Instructions for Australia and New Zealand
    Requests for Refill or Amendment
    - Special Instructions for Australia and New Zealand
    Scientific Report or Notice of Invention error page
  Suppliers
  - Supplier Diversity
    - Amgen's Statement on Supplier Diversity Supplier Diversity Program at Amgen Our Commitment Registering With Amgen Amgen’s Sourcing Categories Affiliations
    Supplier Resources
    - Supplier Procurement Guidelines Procure to Pay System Move Supplier Code of Conduct Conflict Minerals Policy Supplier Invoice Guidelines Supplier Shipping and Receiving Supplier Contact Information Existing Supplier On-Boarding Supplier Terms and Conditions
  Wholesalers
Amgen Binding Corporate Rules
Community Guidelines
COVID-19 Information Center
- Forward-Looking Statements
Amgen Worldwide
Contact Us
- Locations Product Inquiries Website Feedback
Privacy Statement
Global Privacy Statement Directory
Terms of Use